Literature DB >> 15530466

LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy Japanese.

Takashi Miida1, Konen Obayashi, Utako Seino, Ying Zhu, Takako Ito, Keiichiro Kosuge, Satoshi Hirayama, Osamu Hanyu, Yuichi Nakamura, Toshio Yamaguchi, Takashi Tsuda, Yuji Saito, Osamu Miyazaki, Yasushi Nakamura, Masahiko Okada.   

Abstract

BACKGROUND: Prebeta1-HDL acts as a primary acceptor of cellular cholesterol. Prebeta1-HDL is converted into alpha-migrating high-density lipoprotein (HDL) by lecithin/cholesterol acyltransferase (LCAT). We examined whether the LCAT-dependent conversion rate of prebeta1-HDL is a determinant of the plasma prebeta1-HDL concentration in healthy Japanese.
METHODS: We measured the conversion half time (CHT(prebeta1)), the time required for 50% of baseline prebeta1-HDL to be changed into alpha-migrating HDL by LCAT, in 100 healthy Japanese (47 men, 53 women, 22-88 years).
RESULTS: Prebeta1-HDL concentration, as determined by immunoassay, was significantly lower in younger women (<50 years, n=24) than in older women (>or=50 years, n=29) (16.8+/-3.3 vs. 21.7+/-8.0 mg/l apolipoprotein AI (apoAI), p<0.01). There was no significant difference in prebeta1-HDL concentration between younger (n=24) and older (n=23) men (21.2+/-6.8 vs. 22.5+/-6.6 mg/l apoAI). The mean CHT(prebeta1) for all subjects was 47.4+/-13.0 min, and was not influenced by gender or age. Prebeta1-HDL concentration was positively correlated with CHT(prebeta1) in both men and women, suggesting that high prebeta1-HDL levels may reflect delayed conversion of prebeta1-HDL.
CONCLUSION: LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy Japanese. We speculate that prebeta1-HDL concentration may be used as a metabolic marker for HDL maturation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530466     DOI: 10.1016/j.cccn.2004.07.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.

Authors:  Robert D Shamburek; Rebecca Bakker-Arkema; Alexandra M Shamburek; Lita A Freeman; Marcelo J Amar; Bruce Auerbach; Brian R Krause; Reynold Homan; Steve J Adelman; Heidi L Collins; Maureen Sampson; Anna Wolska; Alan T Remaley
Journal:  Circ Res       Date:  2015-12-01       Impact factor: 17.367

2.  HIV infection and high density lipoprotein metabolism.

Authors:  Honor Rose; Jennifer Hoy; Ian Woolley; Urbain Tchoua; Michael Bukrinsky; Anthony Dart; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2007-12-04       Impact factor: 5.162

3.  Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease.

Authors:  Xiao-Min Bu; Dong-Mei Niu; Jia Wu; Yun-Long Yuan; Jia-Xi Song; Jun-Jun Wang
Journal:  Lipids Health Dis       Date:  2017-01-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.